Infantile hypertrophic pyloric stenosis related to ingestion of erythromycine estolate: A report of five cases.
During a 1-yr period an increased incidence of hypertrophic PS was noted in a closed referral population. These patients demonstrated a temporal relationship between the ingestion of EE and the development of PS. A sequence of events from pylorospasm to pyloric tumors was suggested from the data.
D004917:Erythromycin / Q000031:analogs & derivatives*; D004918:Erythromycin Estolate / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006984:Hypertrophy / Q000139:chemically induced / Q000601:surgery; D007231:Infant, Newborn; D008297:Male; D011707:Pyloric Stenosis / Q000139:chemically induced* / Q000601:surgery; D012189:Retrospective Studies; D013997:Time Factors
D004917:Erythromycin; D004918:Erythromycin Estolate